Observational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus Disease
EVISTA
1 other identifier
observational
711
1 country
1
Brief Summary
This study highlighted the possibility, even in epidemic settings, of providing advanced supportive care for patients with VMEs. Indeed, while the prospect of offering any invasive medical care was widely discussed in 2014 in West Africa with the aim of limiting the exposure of caregivers, the epidemic of 2018-2019 has on the contrary seen the development of a number of medical care strategies, in parallel with the deployment of specific treatments. This study aims to describe a cohort of patients receiving this upgraded supportive care during the tenth epidemic in the DRC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
March 17, 2021
CompletedFirst Posted
Study publicly available on registry
March 24, 2021
CompletedMarch 24, 2021
March 1, 2021
1.4 years
March 17, 2021
March 23, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality
Any type mortality during hospitalization
Through the end of the hospitalization, with an average of 11 days
Interventions
(i) advanced clinical and biological monitoring system (ii) symptomatic treatment adapted to the patient's needs, such as antibiotic therapy, oxygen therapy and blood transfusion; (iii) dialysis or mechanical ventilation.
Eligibility Criteria
All patients with positive RT-PCR admitted in ETC's during the inclusion period were included in the study
You may qualify if:
- Laboratory confirmed Ebola Virus Disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BENI ETC
Beni, North Kivu, Democratic Republic of the Congo
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2021
First Posted
March 24, 2021
Study Start
August 1, 2018
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
March 24, 2021
Record last verified: 2021-03